 | Up a level |
Boller, Danielle; Doepfner, Kathrin T; Laurentiis, Angela DE; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; ... (2022). Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours. Anticancer research, 42(6), pp. 3217-3230. International Inst. of Anticancer Research 10.21873/anticanres.15812
Höland, Katrin; Boller, Danielle; Hagel, Christian; Dolski, Silvia; Treszl, András; Pardo, Olivier E.; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Shepherd, Peter R; Styp-Rekowska, Beata; Djonov, Valentin; von Bueren, André O.; Frei, Karl; Arcaro, Alexandre (2014). Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma. PLoS ONE, 9(4), e94132. Public Library of Science 10.1371/journal.pone.0094132
Boller, Danielle; Doepfner, Kathrin T; De Laurentiis, Angela; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; ... (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer research, 32(8), pp. 3015-27. Kapandriti: International Inst. of Anticancer Research
